go back

Indium In-111 Ibritumomab Tiuxetan, Diagnostic

New Jersey rates for HCPCS A9542

Indium In-111 ibritumomab tiuxetan, diagnostic, per study dose, up to 5 mCi

Rates data updated July 2026.

Facilitymedian $5,754 · 10th–90th $2,291$16,2180%10%20%10th90th$5,754Professionalmedian $3,467 · 10th–90th $2,344$3,8020%10%20%10th90th$3,467$100.0$500.0$2.0K$10.0K$50.0K

Distribution of negotiated rates across all payers (price axis is log-scale). Facility and professional rates are different services and are charted separately. Need provider-level prices? Contact us.

Insurance Carrier
Aetna
Setting
Facility
Modifier
Global
Typical Low
$3,548.13
Median
$5,754.40
Typical High
$12,022.64
Aetna
Setting
Professional
Modifier
Global
Typical Low
$2,344.23
Median
$3,467.37
Typical High
$3,801.89
Cigna
Setting
Facility
Modifier
Global
Typical Low
$2,884.03
Median
$3,548.13
Typical High
$4,897.79
Cigna
Setting
Professional
Modifier
Global
Typical Low
$3,548.13
Median
$3,548.13
Typical High
$3,548.13
Emblem Health
Setting
Professional
Modifier
Global
Typical Low
$2,951.21
Median
$2,951.21
Typical High
$2,951.21
Horizon BCBS
Setting
Facility
Modifier
Global
Typical Low
$134.90
Median
$9,332.54
Typical High
$52,480.75
Horizon BCBS
Setting
Professional
Modifier
Global
Typical Low
$2,754.23
Median
$2,754.23
Typical High
$2,754.23
United
Setting
Facility
Modifier
Global
Typical Low
$5,754.40
Median
$5,754.40
Typical High
$5,754.40
United
Setting
Professional
Modifier
Global
Typical Low
$2,511.89
Median
$4,168.69
Typical High
$4,265.80